Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 22;26(41):8969-8975.
doi: 10.1002/chem.202001123. Epub 2020 Jul 8.

Design and Synthesis of 56 Shape-Diverse 3D Fragments

Affiliations

Design and Synthesis of 56 Shape-Diverse 3D Fragments

Thomas D Downes et al. Chemistry. .

Abstract

Fragment-based drug discovery is now widely adopted for lead generation in the pharmaceutical industry. However, fragment screening collections are often predominantly populated with flat, 2D molecules. Herein, we describe a workflow for the design and synthesis of 56 3D disubstituted pyrrolidine and piperidine fragments that occupy under-represented areas of fragment space (as demonstrated by a principal moments of inertia (PMI) analysis). A key, and unique, underpinning design feature of this fragment collection is that assessment of fragment shape and conformational diversity (by considering conformations up to 1.5 kcal mol-1 above the energy of the global minimum energy conformer) is carried out prior to synthesis and is also used to select targets for synthesis. The 3D fragments were designed to contain suitable synthetic handles for future fragment elaboration. Finally, by comparing our 3D fragments with six commercial libraries, it is clear that our collection has high three-dimensionality and shape diversity.

Keywords: 3D fragments; conformational diversity; fragment-based drug discovery; medicinal chemistry; synthesis design.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PMI analysis of potential fragments. A: Conformers of pyrrolidine scaffold 1 (top) and exemplar fragments (bottom). B: Conformers of piperidine scaffold 2 (top) and exemplar fragments (bottom). Compounds with conformations within the grey areas were selected for synthesis. C: Conformers of 33 selected fragments (top) and global minimum energy and selected higher energy 3D conformers of 1 l and 2 j. Red dots indicate global minimum energy conformers and blue dots indicate higher energy conformers.
Scheme 1
Scheme 1
Synthesis of selected 3D fragments.
Figure 2
Figure 2
Additional structurally diverse 3D fragments.
Figure 3
Figure 3
A: PMI plot of the final fragment collection. Red dots indicate global minimum energy conformers and blue dots indicate higher energy conformers. B: Cumulative PMI analysis of the fragment collection (light blue) along with six commercially available libraries.

References

    1. None
    1. Murray C. W., Rees D. C., Nat. Chem. 2009, 1, 187–192; - PubMed
    1. Hubbard R. E., Murray J. B., Methods Enzymol. 2011, 493, 509–531; - PubMed
    1. Congreve M., Chessari G., Tisi D., Woodhead A. J., J. Med. Chem. 2008, 51, 3661–3680; - PubMed
    1. Keserű G. M., Erlanson D. A., Ferenczy G. G., Hann M. M., Murray C. W., Pickett S. D., J. Med. Chem. 2016, 59, 8189–8206; - PubMed

LinkOut - more resources